Intended for healthcare professionals

Rapid response to:

Head To Head

Should drug companies be allowed to talk directly to patients?: NO

BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7402.1302-a (Published 12 June 2003) Cite this as: BMJ 2003;326:1302

Rapid Response:

So who should we trust? It's obvious!

So the Consumers Association conducted a survey in June 2002, which showed that only 25% of the public would trust drug companies to provide them with impartial information.

A survey conducted by a Berkshire general practice, (and still open to patient input) shows that only 0.6% of patients rarely trust information from their GP and 65% always trust the information provided. The survey also shows that 93.9% of respondents believe receiving information from their GP in the form of emails is a GREAT principle.

So we now know who needs to send the information and also the simple, low cost, almost ubiquitous communication medium that can be embraced.
For access to the survey, go to:
http://www.mygeneralpractice.co.uk/binfield and look under services for the Imed(Poll).

Competing interests:  
Marketing manager for MyGeneralPractice; a company set up to help general practices communicate impartial, patient centric, information regularly to their patients.

Competing interests: No competing interests

25 August 2003
David F Danson
Marketing Manager
Dr William Tong, Trevor Clark
MyGeneralPractice Ltd RG42 4EZ